Application of Fuming Tablet Combined with Liraglutide in the Treatment of Diabetic Retinopathy

Objective to investigate the application of fuming Tablet combined with Liraglutid in the treatment of diabetic retinopathy and the effect on the level of insulin-like growth factor-1 (IGF-1) and serum vascular endothelial growth factor (VEGF). Methods: 112 cases of diabetic retinopathy were randomly divided into observation group and control group, 56 cases in each group. The control group was treated with liraglutide, and the observation group was treated with fuming tablet and combined treatment with liraglutide. After 4weeks, 3 months and 6 months, the clinical efficacy, visual acuity, macular thickness, VEGF, IGF-1 and the incidence of adverse reactions in 2 groups were statistically compared. Results: The total effective rate of observation group was higher than that of control group (P<0.05). After treatment, the visual acuity, macular thickness, VEGF and IGF-1 levels in the observation group were lower than those in the control group (P <0.05). Conclusion: Fuming tablet combined with liraglutide can improve visual acuity in patients with diabetic retinopathy.